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How reliable is the history of chickenpox? 
Varicella serology among children up to 14 years of age 
J. Kavaliotis,(l) S. Petridou(l) and D. Karabaxoglou(2) 
Objectives: The aim of this study was to assess the seroprevalence of antibodies to varicella-zoster virus (VZV) in 
children of northern Greece and to estimate the reliability of varicella history. 
Methods: A serosurvey of 632 children, aged 13 months to 14 years (median 5.2 years), was conducted between April 
1999 and July 2001. Serum samples were tested by enzyme-linked immunosorbent assay (ELISA) for IgG antibodies 
to VZV (IgG Genzyme Virotech GmbH). A history of varicella in these children was obtained from the parents of 
all these patients. Also, a check of state health cards of the patients was done. 
Results: Two hundred and forty-eight (39%) of the children were seropositive for VZV. Two hundred and thirty 
(36%) of the 632 children claimed to have had previous varicella infection; 87.8% were seropositive, and 12.2% 
lacked antibodies to VZV. One hundred and seven of the 230 children with a history of varicella had the information 
about the disease confirmed, as it was reported on their state health card by a pediatrician; 10.2% were seronegative 
for VZV. Absence of history of varicella was reported in 402 (63.6%) of the 632 children; 88.6% of those were 
seronegative, and 11.4% were seropositive. The percentage of incorrect negative history ranged from 6% (13-60 
months of age) to 48% (120-168 months of age). 
Conclusions: A large proportion of the study group (61%), mainly below 7 years of age, is susceptible to varicella. 
The positive predictive value of a history of varicella is 87.8%, whereas the negative predictive value of a negative 
history is 11.4%, which means that there is an 88.6% probability of a negative history being correct.Varicella serology 
may be reasonable prior to vaccination in children >lO years old with a negative chickenpox history. However, if one 
excludes cost considerations, it is also reasonable to vaccinate all children, irrespective of serostatus. 
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INTRODUCTION 
Varicella is due to primary infection with varicella-zoster 
virus (VZV) and is manifested with a characteristic 
vesicular exanthem. A history of such exanthem is usually 
strong evidence of varicella infection.1,2 However, 
subclinical infection is well described, mainly in healthy 
adults and less frequently in children.3 The vaccine used 
against varicella is licensed in some countries and will 
soon be licensed in many others. It is generally believed 
that vaccination will have a significant effect against the 
disease.4 However, pediatricians have to perform a 
vaccination based on parent history for varicella or on 
serology for varicella. The cost of each decision is 
different, and the cost of serology varies according to the 
country. A third alternative is to give the vaccine to all 
children, irrespective of history or serostatus. This policy 
has no adverse effects in already immune children; there 
is only the cost of an additional vaccination. 
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The aim of this study was to assess the sero- 
prevalence of antibodies to VZV in children of northern 
Greece, and to estimate the reliability of varicella history. 
This will enable the pediatrician to be better informed 
and will improve clinical policy. 
MATERIALS AND METHODS 
During the period April 1999 to July 2001, a serosurvey 
for antibodies against VZV in children hospitalized in 
our department was conducted. Children admitted for 
varicella were excluded from the study. 
During the study period, serum samples were taken 
from 632 children (study group), aged 13-168 months 
(mean age 62.4 months). All serum samples were taken 
with parental consent. Blood was obtained for other 
investigations, so the venepuncture was not done solely 
for the purpose of this study. Two hundred and forty of 
these patients (53.8%) were male. 
For semiquantitative determination of IgG anti- 
bodies to VZV in serum samples, an enzyme-linked 
immunoassay (ELISA Genzyme Virotech GmbH, 
Russelshlim, Germany) was used. The antibody detected 
in the serum forms an immune complex with the antigen 
coated on the test strips. The enzyme conjugate attaches 
to this complex. After addition of the substrate buffer 
(tetramethylbenzidin (TMB)), a blue dye is produced by 
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the bound enzyme (peroxidase). The color changes to 
yellow when the stopping solution is added. The intensity 
of the color is proportional to the serum concentration 
of antibodies. If the measured values of the samples are 
10% above the cutoff value, the samples are positive, and 
if they are 10% below the cutoff value, the samples are 
negative. The cutoff value given by Virotech has been 
compared with the WHO Serum W1044 and corresponds 
to 250 mIU/mL. The specificity and sensitivity of the 
ELISA are 96% and 91% respectively. 
A history of varicella in these children was obtained 
from the parents. The interview was done before the 
varicella serology results were made available. Parents 
were asked about prior varicella exposure and disease, 
and were given a full description of the clinical mani- 
festations of varicella. We considered only answers that 
definitely supported past chickenpox as being indicative 
of a positive history.The educational status of the parents 
was average for 80%, high for lo%, and elementary for 
10%. Elementary educational status is defined as grade 
school, average status as high school and lyceum, and 
high status as university and technical college. 
All the state health cards of the study group children 
were checked for past varicella diseases. This is an 
official card on which is recorded every examination of 
the children, their vaccinations, diseases, their growth, 
etc. We considered as positive only reports with a 
signature and the name of the pediatrician. 
Infants ~12 months old were excluded from the 
study, first because parents remember the history of 
their child during this small period of time more easily, 
second because the varicella vaccine is licensed for ages 
above 12 months, and third because residual maternal 
antibodies exist. 
Our department is a referral center for varicella in 
an area of about 3 000 000 people, and it is considered 
that the sample is representative of the Greek population. 
RESULTS 
Two hundred and forty-eight (39%) of the children were 
seropositive for VZV antibodies. Two hundred and 
thirty (36.4%) of the 632 patients claimed to have had 
previous varicella; 87.8% of those were seropositive, 
while 12.2% lacked antibodies to VZV (Table 1). The 
percentage of the wrong positive history for varicella 
(no antibodies) was 13.8% (17/123 varied according to 
the age of the patients: 13-60 months, 6/36 (16.7%); 
Table 1. Varicella antibody profile of 632 children 
Varicella No. of Positive Predictive 
history children antibodies value 
No. (%I Positive Negative 
Positive 230 202 87.8 87.8 12.2 
Negative 402 46 11.4 88.6 11.4 
61-120 months, 7/57 (12.2%); 121-168 months, 4/30 
(13.3%)). One hundred and seven of the 230 children 
with positive varicella history had the disease confirmed, 
as it was reported in their state health card by a 
pediatrician; 10.2% of them were seronegative for VZV. 
The percentage of wrong diagnosis by pediatricians in 
cases of a history of varicella varied according to the age 
of the patients: 13-60 months, 4/40 (10%); 61-120 
months, 4/51 (7.8%); 121-168 months, 3116 (18.8%). No 
history of varicella was reported for 402 (63.6%) of the 
632 children; 88.6% of them were seronegative, and 
11.4% were seropositive. Again, the percentage of 
incorrect negative history varied according to age: 13-60 
months, 17/282 (6.0%); 61-120 months, 17/95 (17.9%); 
121-168 months, 12/25 (48%). The distribution of 
antibodies according to age showed that the proportion 
of sera that were positive increased with age (Figure 1). 
The total results according to age are shown in Table 2. 
COMMENTS 
Varicella remains a common, highly infectious and 
sometimes severe disease of childhood. The annual 
incidence of varicella is high in Greece as well as in 
many other parts of the world,1,3%5Jj leading to many 
physician visits and hospitalizations, and much loss of 
employment time. Chickenpox is manifested by a 
characteristic vesicular rash, on which the diagnosis and 
the consequent clinical history are based.l A history of 
previous varicella infection is usually an accurate 
predictor of varicella immunity.1,2,7 However, history 
alone may not be reliable under certain circumstances. 
Subclinical infection has been reported in adults, as well 
as in children.3s The pediatrician must have a clear 
picture of the epidemiology of varicella in order to 
provide a vaccine based on history only or on serology. 
The latter will be cost-effective only if serology is 
cheaper than the vaccine. The alternative of giving the 
vaccine to all children irrespective of history or 
serostatus is a good option if cost is not a factor. It is 
much better to do an additional vaccination (with all the 
known benefits of vaccination) than to lose a 
vaccination because parents will not be back again, or 
will refuse to give a blood sample for serology to 
confirm varicella. The analysis of our data shows that 
10.2% of children with a positive clinical history of VZV 
infection, confirmed by their pediatrician, had no VZV 
antibodies. The corresponding percentage in children 
with varicella history confirmed by their parents was 
12.2%.These percentages are higher than those in other 
studies.9 However, the method of measuring antibodies 
that we used is a sensitive and reliable one, especially for 
epidemiologic purposes, and is comparable with other 
methods (fluorescent antibodies-membrane antigen 
(FAMA etc.)). 810~11 Finally, among children with a 
negative history of chickenpox, varicella seroprevalence 
was 11.4%, ranging from 6% (13-60 months of age) to 
48% (120-168 months of age), a figure smaller than in 
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Figure 1. VZV antibody distribution (%) according to the age of children. 
Table 2. Rate of anti-VZV antibodies and varicella history in 632 children according to age 
Age No. of 
(months) children 
Positive varicella Negative varicella Positive varicella history 
history history by a pediatrician 
No. of (-) vzv No. of (+) vzv No. of (-) vzv 
children antibodies children antibodies children antibodies 
13-24 119 
25-36 106 
37-48 62 
49-60 71 
61-72 67 
73-84 27 
85-96 46 
97-108 35 
109-120 28 
121-132 25 
133-144 21 
145-156 11 
157-168 14 
12 
9 
3 
12 
12 
6 
16 
13 
10 
16 
5 
5 
4 
Total 632 123 
2 
1 
1 
2 
1 
1 
4 
0 
1 
1 
1 
1 
1 
17 
105 3 2 
88 4 9 
44 3 15 
45 7 14 
39 8 16 
13 1 8 
23 3 7 
11 2 11 
9 3 9 
5 0 4 
12 6 4 
4 3 2 
4 3 6 
402 46 107 
0 
1 
1 
2 
1 
0 
0 
1 
2 
1 
0 
1 
11 
other studies.12 Serology would be reasonable in 
patients ~10 years old without a history of varicella. 
In our study, the rate of susceptibility to varicella in 
children is high. This rate is higher than in other 
studies.9,13v14 Therefore, the widespread use of varicella 
vaccine should have a significant impact on the 
epidemiology of varicella-zoster infections. 
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